- Open Access
The effects of hyperoxia on microvascular endothelial cell proliferation and production of vaso-active substances
Intensive Care Medicine Experimental volume 5, Article number: 22 (2017)
Hyperoxia, an arterial oxygen pressure of more than 100 mmHg or 13% O2, frequently occurs in hospitalized patients due to administration of supplemental oxygen. Increasing evidence suggests that hyperoxia induces vasoconstriction in the systemic (micro)circulation, potentially affecting organ perfusion. This study addresses effects of hyperoxia on viability, proliferative capacity, and on pathways affecting vascular tone in cultured human microvascular endothelial cells (hMVEC).
hMVEC of the systemic circulation were exposed to graded oxygen fractions of 20, 30, 50, and 95% O2 for 8, 24, and 72 h. These fractions correspond to 152, 228, 380, and 722 mmHg, respectively. Cell proliferation and viability was measured via a proliferation assay, peroxynitrite formation via anti-nitrotyrosine levels, endothelial nitric oxide synthase (eNOS), and endothelin-1 (ET-1) levels via q-PCR and western blot analysis.
Exposing hMVEC to 50 and 95% O2 for more than 24 h impaired cell viability and proliferation. Hyperoxia did not significantly affect nitrotyrosine levels, nor eNOS mRNA and protein levels, regardless of the exposure time or oxygen concentration used. Phosphorylation of eNOS at the serine 1177 (S1177) residue and ET-1 mRNA levels were also not significantly affected.
Exposure of isolated human microvascular endothelial cells to marked hyperoxia for more than 24 h decreases cell viability and proliferation. Our results do not support a role of eNOS mRNA and protein or ET-1 mRNA in the potential vasoconstrictive effects of hyperoxia on isolated hMVEC.
Supplemental oxygen (O2) is frequently administered in the hospital, especially in critically ill patients. For years, oxygen therapy focused on avoiding hypoxia, arterial oxygen levels below 70 mmHg or 9% O2, often accepting a state of hyperoxia, arterial oxygen levels of more than 100 mmHg or 13% O2 . The consequences of hyperoxia, however, remain unclear and have been a topic of debate for several decades in which both beneficial as well as deleterious effects have been reported [2–5].
Clinically, hyperoxia is associated with negative outcomes such as acute lung injury , increased infarct size in patients with a myocardial or cerebral infarction [7, 8] and increased mortality in patients after cardiac arrest [9, 10]. In contrast, others report beneficial effects with improved organ function after cardiac arrest  and antimicrobial activity with a reduction of surgical site infections [12, 13].
Furthermore, hyperoxia can cause significant hemodynamic alterations [2, 3] and has been reported to induce vasoconstriction in several (cerebral, coronary, skeletal muscle, and retinal) [14–17], but not all (renal, mesenteric) [18, 19], vascular beds. This vasoconstriction appears mainly to occur at microvascular level, since the diameter of large conduit arteries remains constant [15, 20]. It may lead to heterogeneity of the microcirculation with loss of functional capillary density and impaired organ perfusion [3, 21], but may also stabilize hemodynamics in vasodilatory shock . In addition, other studies show that hyperoxia is able to redistribute blood flow which can protect hepatosplanchic organs and the kidneys [22, 23].
Crucial in the pathophysiology of a large variety of clinical conditions, such as sepsis, trauma, or ischemia/reperfusion injury is microvascular dysfunction. Hyperoxia is thought to increase reactive oxygen species (ROS) which can damage the endothelium and can worsen microvascular dysfunction with increased permeability, local inflammation and coagulation, and disturbed hemodynamics [24, 25]. It is therefore important to gain more insight in the effects of hyperoxia on the microvascular endothelium.
Several studies investigated the direct effects of hyperoxia on cultured endothelial cells with controversial results. Exposure to hyperoxia exerted a toxic effect with induction of cell death and reduced cellular proliferation in several cell types, such as human lung microvascular endothelial cells and bovine adrenal capillary endothelial cells [26, 27]. Exposure to hyperoxia also led to an inflammatory status by increasing the expression of inflammatory molecules, such as intercellular adhesion molecule 1 (ICAM-1) in human pulmonary artery endothelial cells and human umbilical vein endothelial cells . Conversely, other studies showed that hyperoxia decreased the number of apoptotic cells and had anti-inflammatory effects in a rat intestinal ischemia-reperfusion and sepsis model [29, 30].
The exact underlying mechanisms of vasoconstriction following hyperoxia however remain unclear. The majority of the studies indicate a central role for the endothelium [16, 34, 35]. Increased oxidative stress can augment the formation of peroxynitrite (ONOO−), which is formed when superoxide (O2 −) reacts with nitric oxide (NO), resulting in a reduced bioavailability of NO . NO itself is crucial for endothelium-driven vasodilation and vascular homeostasis . It has also been hypothesized that hyperoxia decreases NO levels by affecting endothelial nitric oxide synthase (eNOS), the main enzyme responsible for the production of NO by the endothelium [34, 35]. Another potential pathway is a hyperoxia-induced decrease of cyclooxygenase (COX) activity in endothelial cells, thereby possibly lowering the levels of vasodilatory prostaglandins . Interestingly enough the effects of hyperoxia on the protein endothelin-1 (ET-1), which is a potent vasoconstrictor, remain scarcely investigated .
Studies investigating the effects of hyperoxia on vascular smooth muscle cells (VSMC) showed that hyperoxia can induce vasoconstriction via L-type calcium and by influencing 20-hydroxyeicosatetraenoic acid (20-HETE) production [40, 41].
Unfortunately, most animal and in vitro studies only investigated extreme hyperoxia (i.e. 95% O2), often using endothelial cells from the retinal or pulmonary circulation [16, 33, 34, 38, 42–46]. Studies using endothelial cells of the systemic microcirculation and milder degrees of hyperoxia are scarce.
Taken together, several lines of evidence suggest that hyperoxia affects endothelial cell viability and proliferative capacity, but also promotes vasoconstriction primarily via the endothelium. In this study the effects of hyperoxia on isolated human microvascular endothelial cells (hMVEC) were investigated, using a clinically relevant scale of oxygen exposure. We investigated the effects of hyperoxia on cell viability and proliferation. We also addressed potential underlying mechanisms by which hyperoxia induces toxicity and vasoconstriction by studying peroxynitrite formation via protein tyrosine nitration capacity, the NO pathway via eNOS mRNA and protein levels and ET-1 mRNA production.
The study was executed in accordance with the Declaration of Helsinki and was approved by the University Human Subjects Committee of the VU University Medical Center. Written informed consent was obtained from all healthy donors in accordance with the institutional guidelines. All healthy foreskins were collected anonymously and were kindly provided by the Department of Dermatology (VUmc, Amsterdam). Human microvascular endothelial cells (hMVEC) were isolated from the foreskins and characterized, as previously described, by the presence of CD31, VE-cadherin, and Von Willebrand factor . Cells were cultured on gelatin-coated wells (1% w/v) in EBM-2 medium supplemented with EGM-2 MV SingleQuots, 100 U/ml penicillin, 100 mg/ml streptomycin (p/s), 2 mM L-glutamine, 5 U/ml heparin (all from Lonza, Verviers, Belgium). The fetal calf serum (FCS) was replaced with 10% human platelet lysate (hPL) which was acquired as previously described . Cells were cultured in an incubator kept at 37°C with 95% air, 5% CO2, and 95% humidity. Since the cells were cultured under 5% CO2, the oxygen exposure changed from atmospheric levels (21% O2) to 20% O2. Confluent cells were washed with 0.5 mM EDTA (Merck Milipore, MA, USA) in HBSS and were trypsinized with 0.05% trypsin in EDTA/HBSS (Lonza, Verviers, Belgium). At least three cell donors from passage 9–11 were used for all the experiments.
Cells of a single donor were cultured on four different culture plates. The plates were placed in airtight acryl boxes with moist tissues to maintain humidity. At the start of each experiment, the boxes were flushed for 5 min with the indicated oxygen concentration (Table 1) by using two outlets. The boxes were thereafter placed in an incubator and kept at 37 °C. Oxygen concentration in the boxes was measured at the start and end of each experiment (Additional file 1: Figure S1) using the Microx 4 (PreSens, Regensburg, Germany). Experiments were halted if the boxes proved not to be airtight, as determined by a drop in oxygen concentration.
A proliferation assay was performed to determine the effects of hyperoxia on cell death and proliferative capacity. Endothelial cells were exposed to 20% (control), 50, and 95% O2 for 3 days. Exposure to 30% O2 was not performed in this assay, due to limitations in the number of airtight boxes. Furthermore, pilot experiments showed that exposure to 30% O2 did not affect cell death and proliferative capacity when compared to 20% O2 (control). Cells from three donors were pooled and seeded in duplicate with a density of 13 × 103 cells/cm2 on 12 wells 1% w/v gelatin-coated culture plates. The plates were placed in airtight boxes and were exposed to the indicated oxygen concentration. Pictures were taken every 24 h using a phase-contrast microscope. Cells were counted using ImageJ version 1.49.
Formation of peroxynitrite (ONOO−) was measured indirectly using anti-nitrotyrosine antibodies as previously validated [49, 50]. For this assay hMVECs were cultured in 8-well immunofluorescence μ-slides (Ibidi, Planegg, Germany, 80826). The slides were coated with 1% w/v gelatin which was cross-linked for 15 min using 2% glutaraldehyde (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C. Cells were exposed to the various oxygen concentrations in airtight boxes for 24 h. The cells were thereafter washed using phosphate-buffered saline (PBS), were fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich) for 15 min, and were permeabilized using 0.2% triton X-100 (Merck Millipore) for 5 min. The cells were incubated with the primary polyclonal rabbit anti-human anti-nitrotyrosine antibody (Life Technologies, Bleiswijk, The Netherlands) diluted (1:75) in PBS with 0.1% albumin (PBS-A, Sigma-Aldrich) overnight at 4 °C. The following day, the slides were washed using PBS with 0.05% Tween (PBS-T, Sigma-Aldrich) for 5 min. The slides were then incubated for 1 h with Alexa Fluor 488 conjugated donkey anti-rabbit secondary antibody (Molecular Probes Europe, Leiden, The Netherlands) (1:50) in PBS-A. Afterwards, the slides were washed with PBS-T and were mounted using Ibidi Mounting Medium (Ibidi, Planegg, Germany).
The immunofluorescence was determined using a Zeiss Axiovert 200 M Marianas™ inverted microscope (Carl Zeiss, Jena, Germany). The microscope, camera, and data were controlled by SlideBook™ software (SlideBook™ (Intelligent Imaging Innovations, Denver, CO, USA). SlideBook software was also used to determine the mean fluorescence intensity (MFI) per cell.
The effects of hyperoxia at the ET-1 mRNA level and the EDN1 gene were investigated by using quantitative PCR (q-PCR). For this assay, total RNA was isolated using the RNeasy Micro kit according to the manufacturer’s protocol (Qiagen, Hilden, Germany). The RNA quality and concentration was determined by Nanodrop (ISOGEN Life science, De Meern, The Netherlands). 100 μl total copy DNA (cDNA) was synthesized from 1000 ng/ml RNA with the cloned AMV First-Strand cDNA synthesis kit (Invitrogen). Q-PCR was performed in duplicate using Sybr Green (MESA Green QPCR Mastermix Plus for Sybr Assay, Eurogentec, Seraing, Belgium) in an ABI7500 RT-PCR machine (Applied Biosystems, Foster City, USA). Primers were self-designed and synthesized by Invitrogen (Invitrogen, Carlsbad, USA) (Table 2). Primer specificity was tested by homology search with the human genome (BLAST) and was confirmed by dissociation curve analysis. Relative expression levels (N-fold differences) of target genes were calculated using the delta delta Ct method, as previously described .
Endothelial nitric oxide synthase (eNOS)
NO is difficult to measure directly due to its instability. The effects of hyperoxia were therefore determined on eNOS, the key enzyme responsible for NO generation in endothelial cells. The effects were investigated at the mRNA level, using q-PCR as described above. Protein expression and phosphorylation status of the serine 1177 (S1177) residue were determined using western blot.
For the western blot assay cell lysates of hMVEC were prepared by scraping the wells on ice using a rubber policeman and by adding Roche lysis buffer with phosphatase and protease inhibitors (Roche, Mannheim, Germany). Protein concentrations were determined using a Bradford assay. The lysates were mixed with Laemmli sample buffer (Bio-Rad, Hercules, USA) with 5% β-mercaptoethanol and were boiled for 5 min at 95 °C. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed using a 6% gel. Proteins were blotted onto nitrocellulose membranes and were blocked with 5% BSA in tris-buffered saline with 0.05% Tween (TBS-T) for 1 h. Membranes were probed with the primary rabbit polyclonal antibodies (1:1000 in 5% BSA in TBS-T; eNOS, ABCAM; peNOS S1177, Cell signaling; ACTN-1, Life Technologies) overnight at 4 °C. Blots were washed the following day and were probed with a secondary goat-anti rabbit horseradish peroxidase-conjugated antibody (1:2000 in 5% BSA in TBS-T; Dako, Glostrup, Denmark) for 90 min at room temperature. The bands were visualized with enhanced chemiluminescence (GE Healthcare) on a LAS3000 machine (FUJIFILM).
Statistical analyses were performed by one-way ANOVA with a post hoc Bonferroni test. The results were graphed using GraphPad Prism 6.0 for windows (GraphPad Software Inc, La Jolla, CA, USA). P < 0.05 was considered significant. The results are given as mean ± standard deviation (SD). 20% O2 was used as a control, since the cells were isolated and cultured under 20% O2, and an experimental setup using lower and more physiological levels of oxygen exposure as a control is not feasible in an in vitro setup. All hyperoxic conditions (30, 50, and 95% O2) were compared to 20% O2.
Hyperoxia and cell proliferation
A proliferation assay was performed with a pool of three different cell donors to test if microvascular endothelial cells could withstand exposure to hyperoxia (Fig. 1). In this experiment, the wells were seeded in duplicate with 13 × 103 cells/cm2. After initial seeding, not all cells adhered to the matrix, and the starting point was 7.9 × 103 ± 0.2 × 103 (mean ± SD) cells/cm2 for all conditions. Under 20% O2 (control) cells proliferated to 52 × 103 ± 1.8 × 103 cells/cm2 after 3 days, with a typical cobblestone morphology (Fig. 1a, Inset). Exposure to 50% O2 slightly reduced the proliferation to 39 × 103 ± 7.0 × 103 cells/cm2 at day 3 (Fig. 1d). The cells did however keep their cobblestone morphology after 72 h of exposure (Fig. 1b, Inset). Exposure to 95% O2 showed an initial increase in proliferation, which started to decrease after 24 h of exposure. This decrease became more pronounced as exposure time increased. Exposure to 95% O2 for 48 h resulted in 13.6 × 103 ± 1.2 × 103 cells/cm2. Exposure to 95% O2 for 72 h however showed a decrease to 9.3 × 103 ± 0.2 × 103 cells/cm2 indicating cell death. This was also confirmed by the observation of endothelial cells detaching from the matrix and floating within the cell culture media under the microscope. Exposure to 95% O2 also led to a more stressed morphology of cells, visible as stretched cells under the microscope. This was possibly due to lack of cell confluence following cell death and reduced proliferation (Fig. 1c, inset).
Hyperoxia and peroxynitrite
Immunofluorescence experiments were performed with three different cell donors in order to determine if hyperoxia affects the formation of peroxynitrite. Anti-nitrotyrosine antibodies were used for these experiments. Under normal culture conditions, the nitrotyrosine signal was observed predominantly in the proximity of the nuclei and cytoplasm of the fixated endothelial cells (Fig. 2a, inset). Exposure to 50 or 95% O2 for 24 h did not alter the nitrotyrosine localization (Fig. 2b, c). Exposure to hyperoxia did not increase nitrotyrosine levels in cultured hMVEC (Fig. 2d), indicating no rise in peroxynitrite levels, due to increased O2.
Hyperoxia and eNOS
In order to determine if hyperoxia leads to vasoconstriction via a NO pathway, the effects were determined on both mRNA and protein levels of the enzyme eNOS, with at least three different cell donors. After 8, 24, and 72 h of exposure, eNOS mRNA levels did not change significantly compared to 20% O2 (control) (Fig. 3). Exposure to 95% O2 for 72 h did lead to a trend of decreased eNOS expression, which was not significant (P = 0.067).
No significant change was seen on eNOS protein levels after exposure to hyperoxia for 8, 24, and 72 h. Interestingly, an exposure time of 72 h gave an almost exact trend as an exposure time of 24 h. This trend is characterized by an initial increase followed by a decrease of the eNOS protein as oxygen concentrations increased.
The effects of hyperoxia were also determined with regards to the ratio of peNOS/eNOS, which is the ratio of the activated form of eNOS divided by the total eNOS protein.
Exposure to hyperoxia for 8 h gave a trend of a decreased expression of the ratio when exposed to different degrees of hyperoxia. Exposure for 24 and 72 h however gave a trend of increased expression of the ratio when exposed to different degrees of hyperoxia. These observed trends in the phosphorylation status were not statistically significant (Fig. 4).
Hyperoxia and ET-1
The effects of hyperoxia on the mRNA levels of the potent vasoconstrictor ET-1 were also determined with four different cell donors.
Exposure to hyperoxia for 8 h led to a trend of increased expression of ET-1 mRNA when compared to 20% O2 (control). Exposure for 24 h led to an increase of 1.41 when the cells were exposed to 95% O2. Exposure for 72 h to 30 and 50% O2 led to a slightly decreased expression of 0.73 and 0.68 when compared to 20% O2 (control). Exposure to 95% O2 gave rise to a minor increase of 1.23 in the ET-1 mRNA expression. None of these changes were statistically significant (Fig. 5)
This cell culture study showed that exposure of isolated human systemic microvascular endothelial cells to 50% O2 for more than 24 h slightly affected cell proliferation, but exposure to 95% O2 for more than 24 h markedly reduced cell viability and proliferative capacity. Exposure to hyperoxia for 8, 24, and 72 h did not lead to a significant change in protein tyrosine nitration by peroxinitrite. Furthermore, exposure to hyperoxia did not significantly affect eNOS mRNA, protein, or serine-phosphorylation levels, nor did it alter the levels of ET-1 mRNA.
To the best of our knowledge, the current study is the first to investigate the role of hyperoxia on isolated cultured human endothelial cells of the systemic microcirculation using different degrees of hyperoxia. Systemic microvascular endothelial cells are particularly relevant, since in critically ill patients (who are most frequently exposed to hyperoxia during mechanical ventilation) microvascular dysfunction plays a pivotal role in conditions such as sepsis, trauma, and ischemia/reperfusion injury. An increase of microvascular endothelial injury, which is the largest endothelial surface of the body, may worsen organ failure.
Exposure to extreme hyperoxia (95% O2) in our study did not stop microvascular endothelial cell proliferation in the first day, but after 24 h, cell densities started to decrease which became more pronounced as exposure time increased. Exposure for 72 h decreased total cell numbers back towards seeding densities, indicating cell death. The toxic effects of extreme hyperoxia were also shown in a recent study which exposed human umbilical endothelial cells (HUVEC) to 95% O2 . This study showed that the total number of cells remained equal after 8 h of exposure, whereas the number of apoptotic and dead cells had increased. After 72 h there was a 15% decrease in alive cells compared to 21% O2, which was used as a control. The toxic effects of extreme hyperoxia appear to differ between vascular beds. Pulmonary endothelial cells seem to be more resistant to the toxic effects of oxygen. In a study exposing isolated human microvascular endothelial cells of the lung to 95% O2, cell death was minimal until day 4 . In another study, bovine pulmonary artery cells exposed to 95% O2 showed normal morphology, and no changes in cell number after 72 h compared to 21% O2, whereas bovine carotid artery endothelial cells developed irregular, atrophic, and distorted shapes after 48 h of exposure with a reduction to 63% of the control number of cells by 72 h .
With regard to moderate hyperoxia, in our study, exposure of systemic microvascular endothelial cells to 50% O2 for more than 24 h slightly reduced cell proliferation, but not viability. Similarly, a study of isolated bovine adrenal capillary endothelial cells reported that the proliferation was inhibited after 24 h of exposure to 40% O2. The cell number did not decrease in this study, but remained stable for the duration of the experiments, which was 6 days . In a very recent study, HUVEC exposed to 40% O2 showed a significant reduction in viable cell count after 24 h . In contrast, bovine carotid artery endothelial cells and bovine pulmonary artery endothelial cells exposed to 60% O2 did not show changes in morphology or cell number after 72 h of exposure .
Taken altogether, these results suggest that not only extreme hyperoxia, but also the clinically more relevant moderate hyperoxia may harm the microvascular endothelium. However, the response to extreme and moderate hyperoxic exposure can differ in endothelial cells from different vascular beds and different species . In this in vitro study, we investigated whether the ROS peroxynitrite, measured by nitrotyrosine as an indirect marker, played a role in the toxic effects of hyperoxia. Exposure to hyperoxia did not significantly increase the nitrotyrosine signal within systemic microvascular endothelial cells. We hypothesize that exposure to hyperoxia might not lead to an increase in ROS via a peroxynitrite pathway in cultured endothelial cells. However, it is possible that basal NO levels were too low in this study to be able to increase the peroxynitrite levels adequately, since peroxynitrite formation is dependent on both O2 − as well as NO. This is in line with a previous study, which reported that hyperoxia only increases peroxynitrite formation after the addition of exogenous NO . Our findings however do not exclude an increase in other ROS, as suggested by a study in rat pulmonary capillary endothelial cells . In this study, exposure to hyperoxia increased oxidative stress, as was estimated by 2′,7′-dichlorofluorescein (DCF) which does not specify the type of ROS involved.
Our study investigated potential underlying mechanisms by which hyperoxia induces vasoconstriction. Exposure to extreme and moderate hyperoxia did not significantly affect eNOS mRNA, protein, or serine-phosphorylation levels, nor did it alter the levels of ET-1 mRNA. There are several explanations for these results.
First, it is possible that isolated endothelial cells are not a suitable model to study hyperoxic vasoconstriction. It could be that the O2 sensor is not located in the endothelium, but in other cells of the arteriolar wall (vascular smooth muscle cells), intraluminal (red blood cells), or in extravascular cells (parenchymal cells or mast cells). In addition, interaction with extravascular cells and smooth muscle cells may be necessary to activate the signaling pathway that couples changes in arteriolar oxygen pressure to changes in arteriolar tone .
Second, our in vitro model may not be suitable to investigate hyperoxic vasoconstriction, since NO availability is not guaranteed. In our study, no significant effect of hyperoxia on eNOS mRNA, protein levels, or serine-phosphorylation levels was found. However, the majority of studies in the literature point in the direction of a reduced bioavailability of NO as the underlying mechanism of hyperoxic vasoconstriction [32–35]. But for a model to show an effect on NO, the NO availability at the start of the experiment should be comparable to in vivo situations. The isolated endothelial cells were not exposed to flow, which may have decreased their basal NO level [56, 57].
Furthermore, it is possible that supporting leukocytes are needed in order to increase the NO levels. Hyperoxia can lead to an inflammatory status of the vascular system . During this inflammation, NO production can be greatly increased by mainly macrophages, which possess the enzyme inducible nitric oxide synthase (iNOS). In the latter situation, an increase in peroxynitrite levels can be expected since both the NO as well as the O2 − will be increased . These results could not be reproduced in our study, since iNOS regulation is largely controlled via macrophages and not endothelial cells .
However, another possible explanation for our negative results with regard to the NO pathway can be that hyperoxia does influence NO bioavailability, but that we were not able to detect it, since it is not possible to measure NO directly.
Third, another reason for the lack of effect of hyperoxia on eNOS and ET-1 in our study may be that hyperoxia induces vasoconstriction by affecting other vaso-active mediators. Several studies suggest a role for prostaglandins [16, 38] or 20-hydroxyeicosatetraenoic acid (20-HETE), a vasoconstrictor which is formed in vascular smooth muscle cells (VSMC) by the CYP450-4A enzyme system [40, 41, 43, 60]. In contrast with our ET-1 findings in human endothelial cells of the systemic microcirculation, hyperoxia did increase ET-1 levels in isolated bovine adrenal capillary endothelial cells and bovine retinal endothelial cells . The difference in results can be based on species variability or upon different vascular origin of the endothelial cells used. Furthermore, we investigated ET-1 only at the mRNA and not the protein level, since general consensus within the literature states that the bioavailability of the ET-1 protein is predominately regulated at the transcriptional level of the EDN1 gene . Therefore, we cannot exclude the possibility that ET-1 was affected at translation or posttranslational level.
Fourth, the negative results with regard to vasoconstrictive pathways may be caused by the use of 20% O2 as a control for cultured endothelial cells, because the cells were isolated and cultured under these conditions. Twenty percent of O2, however, is already hyperoxic in vivo, especially at tissue level . This may have attenuated the differences between the groups.
Fifth, hyperoxia might not stimulate vasoconstrictive pathways in these specific microvascular endothelial cells derived from the foreskin, since the effect of hyperoxia on vascular tone varies between different vascular beds. For example, hyperoxia induced vasoconstriction in coronary arteries of pigs [34, 63] and in carotid vessels from dogs , but induced vasodilation in renal vessels of the dog , whereas no response to hyperoxia was observed in the arterioles of the mesentery of the rat and cat [19, 66].
More research is needed exploring the abovementioned pathways in an isolated and combined way in vitro as well as in vivo. Studies combining cultured endothelial cells, leukocytes, and vascular smooth muscle cells with flow and inflammatory stimuli can help to further unravel the mechanisms behind hyperoxic vasoconstriction.
Several limitations exist in this study. For all experiments, at least three different cell donors were used to correct for donor variability. Although this is not uncommon within in vitro literature, the power of our study is limited. Another possible limitation is the use of 20% O2 as a control for the experiments, because the endothelial cells were isolated and cultured under these conditions. 20% O2 is however already hyperoxic for endothelial cells in vivo . However, performing experiments using physiological levels of oxygen exposure as a control would require endothelial cells to be isolated and cultured continuously within a hypoxic chamber. This is not feasible within an in vitro setup. Performing experiments using 20% O2 as a control is common practice and a limitation within in vitro literature in general. We did consider this point and repeated the eNOS and ET-1 experiments by exposing them to 10% O2 (=76 mmHg) (Additional file 1: Figure S2). This did not lead to significantly different outcomes of the experiments. A limitation of this study was the fact that the cells could only be cultured under hyperoxia for a maximum of 72 h. After 72 h, the culture media needed to be refreshed and the airtight boxes opened. This would decrease the oxygen concentration within the boxes back to atmospheric conditions. Experiments investigating hyperoxic exposure for short time periods (i.e., <1 h) were also not performed in this study. In addition, cell proliferation and viability experiments were not performed under mild hyperoxic (30% O2) conditions. Furthermore, this study investigated ET-1, via mRNA and eNOS, via mRNA and protein levels and did not investigate downstream pathways of NO generation or breakdown. Neither were other pathways investigated such as 20-HETE or prostaglandin production. Finally, our isolated hMVEC model precluded measuring hyperoxic effects mediated by the interaction between endothelial cells, leukocytes, and vascular smooth muscle cells and excluded the interaction with flow and circulating mediators.
The present model of isolated and cultured human microvascular endothelial cells suggests that not only extreme hyperoxia (95% O2), but also the clinically more relevant moderate hyperoxia (50% O2) for more than 24 h may harm the microvascular endothelium. This is especially relevant for critically ill patients, where microvascular dysfunction is frequently present. Hyperoxia may worsen microvascular endothelial injury and may contribute to multiple organ failure. Because control experiments in vitro were done under hyperoxic conditions (20% O2) relative to the real tissue conditions in vivo, already beginning toxic effects in the controls (20% O2) cannot be excluded. Peroxynitrite did not seem to play a major role in the reduced viability and proliferation in vitro. Furthermore, in this model of isolated systemic human microvascular endothelial cells hyperoxia did not affect several key elements of the vaso-active response, namely, eNOS mRNA and protein and ET-1 mRNA levels. Hyperoxic vasoconstriction remains a complex mechanism, and it is possible that isolated in vitro models alone are not sufficient to study this mechanism. To show the full impact of endothelial responses to hyperoxia, models that allow the interaction between endothelial cells, leukocytes, and vascular smooth muscle cells in combination with flow and inflammatory stimuli are likely more appropriate.
Bovine serum albumin
Endothelial nitric oxide synthase
Fetal calf serum
Human Microvascular Endothelial Cells
Human platelet lysate
Human umbilical vein endothelial cells
Intercellular adhesion molecule 1
Inducible nitric oxide synthase
Mean fluorescence intensity
- O2 :
- O2 − :
- ONOO− :
Reactive oxygen species
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
de Graaff AE, Dongelmans DA, Binnekade JM, de Jonge E (2011) Clinicians’ response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med 37:46–51
Sjöberg F, Singer M (2013) The medical use of oxygen: a time for critical reappraisal. J Intern Med 274:505–528
Cornet AD, Kooter AJ, Peters MJ, Smulders YM (2013) The potential harm of oxygen therapy in medical emergencies. Crit Care 17:313
Cornet AD, Kooter AJ, Peters MJSY (2012) Supplemental oxygen therapy in medical emergencies: more harm than benefit? Arch Intern Med 172:289–290
Calzia E, Asfar P, Matejovic M et al (2010) Hyperoxia may be beneficial. Crit Care Med 38:559–568
Kallet RH, Matthay MA (2013) Hyperoxic acute lung injury. Respir Care 58:123–141
Rawles JM, Kenmure AC (1976) Controlled trial of oxygen in uncomplicated myocardial infarction. BMJ 1:1121–1123
Rønning OM, Guldvog B (1999) Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 30:2033–2037
Wang C, Chang W, Huang C et al (2014) The effect of hyperoxia on survival following adult cardiac arrest : a systematic review and meta-analysis of observational studies. Resuscitation 85:1142–1148
Pilcher J, Weatherall M, Shirtcliffe P et al (2012) The effect of hyperoxia following cardiac arrest a systematic review and meta-analysis of animal trials. Resuscitation 83:417–422
Elmer J, Scutella M, Pullalarevu R et al (2015) The association between hyperoxia and patient outcomes after cardiac arrest : analysis of a high-resolution database. Intensive Care Med 41:49–57
Knighton D, Halliday B, Hunt T (1984) Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg 119:199
Belda JF, Aguilera L, García de la Asunción J et al (2005) Supplemental perioperative oxygen and the risk of surgical wound infection a randomized controlled trial. JAMA J Am Med Assoc 294:2035–2042
Floyd TF, Clark JM, Gelfand R et al (2003) Independent cerebral vasoconstrictive effects of hyperoxia and accompanying arterial hypocapnia at 1 ATA. J Appl Physiol 95:2453–2461
Mcnulty PH, Robertson BJ, Tulli MA et al (2007) Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol 13326:2040–2045
Messina JE, Sun D, Koller A et al (1994) Increases in oxygen tension evoke arteriolar constriction by inhibiting endothelial prostaglandin synthesis. Microvasc Res 40:151–160
Kiss B, Polska E, Dorner G et al (2002) Retinal blood flow during hyperoxia in humans revisited: concerted results using different measurement techniques. Microvasc Res 64:75–85
Sharkey RA, Mulloy EMT, Neill SJO (1998) Acute effects of hypoxaemia, hyperoxaemia and hypercapnia on renal blood flow in normal and renal transplant subjects. Eur Respir J 12:653–657
Lang J, Johnson PC (1988) Elevated ambient oxygen does not affect autoregulation in cat mesentery. Am J Physiol 255:131–137
Farquhar H, Weatherall M, Wijesinghe M, Perrin K (2009) Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 158:371–377
Kamler M, Wendt D, Pizanis N et al (2004) Deleterious effects of oxygen during extracorporeal circulation for the microcirculation in vivo. Eur J Cardiothorac Surg 26:564–570
Barth E, Bassi G, Maybauer DM et al (2008) Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 36:495–503
Barth E, Bassi G, Simon F, Gro M (2009) Hemodynamic, metabolic, and organ function effects of pure oxygen ventilation during established fecal peritonitis-induced septic shock. Crit Care Med 37:2465–2469
Brueckl C, Kaestle S, Kerem A et al (2006) Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol 34:453–463
Ming L, Ping F, Yao X et al (2006) Reactive oxygen species in vascular wall. Cardiovasc Haematol Disord Targets 6:1–19
Amore PAD, Sweet E (1987) Effects of hyperoxia on microvascular cells in vitro. Vitr Cell Dev Biol 23:123–128
Narula P, Xu J, Kazzaz JA et al (1998) Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells. Am J Physiol 274:411–416
Suzuki Y, Aoki T, Takeuchi O et al (1997) Effect of hyperoxia on adhesion molecule expression in human endothelial cells and neutrophils. Am J Physiol Lung Cell Mol Physiol 16:418–425
Sukhotnik I, Brod V, Lurie M et al (2009) The effect of 100% oxygen on intestinal preservation and recovery following ischemia-reperfusion injury in rats. Crit Care Med 37:1054–1061
Waisman D, Brod V, Rahat MA et al (2012) Dose-related effects of hyperoxia on the lung inflammatory response in septic rats. SHOCK 37:95–102
Gu X, El-Remessy AB, Brooks SE et al (2003) Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 285:C546–C554
Chen Z, Wen L, Marin M et al (2015) Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation 2:805–814
Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822–H827
Pasgaard T, Stankevicius E, Jørgensen MM et al (2007) Hyperoxia reduces basal release of nitric oxide and contracts porcine coronary arteries. Acta Physiol 191:285–296
Pries AR, Heide J, Ley K et al (1995) Effect of oxygen tension on regulation of arteriolar diameter in skeletal muscle in situ. Microvasc Res 49:289–299
Gryglewski RJ, Palmer RMJ, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 320:454–456
Behrendt DPG (2002) Endothelial function: from vascular biology to clinical applications. Am J Cardiol 9149:40–48
Ishii Y, Morita I, Murota S, Kitamura S (1993) Hyperoxia decreases cyclooxygenase. Prostaglandins Leukot Essent Fat Acids 48:455–461.
Stow LR, Jacobs ME, Wingo CS, Cain BD (2011) Endothelin-1 gene regulation. FASEB J 25:16–28
Ngo AT, Riemann M, Torp-pedersen C, Jensen LJ (2013) Significance of K ATP channels, L-type Ca 2 + channels and CYP450-4A enzymes in oxygen sensing in mouse cremaster muscle arterioles In vivo. BMC Physiol 13:1–11
Welsh DG, Jackson WF, Segal SS (1998) Oxygen induces electromechanical coupling in arteriolar smooth muscle cells: a role for L-type Ca2+ channels. Am J Physiol 274:H2018–H2024
Block RE, Patel MJ, Angelides JK et al (1986) Hyperoxia reduces plasma membrane fluidity : a mechanism for endothelial cell dysfunction. J Appl Physiol 60:826–835
Frisbee JC, Krishna UM, Falck JR, Lombard JH (2001) Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries. Microvasc Res 62:271–283
Riemann M, Rai A, Ngo AT et al (2010) Oxygen-dependent vasomotor responses are conducted upstream in the mouse cremaster microcirculation. J Vasc Res 48:79–89
Clement A, Hubscher U (1985) Effects of hyperoxia on DNA synthesis in cultured porcine aortic endothelial cells. J Appl Physiol 59:1110–1116
Willam C, Schindler R, Frei U, Eckardt K (1999) Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am J Physiol 276:H2044–H2052
Van Hinsbergh VW, Sprengers EDKT (1987) Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 57:148–153
Tasev D, van Wijhe MH, Weijers EM et al (2015) Long-term expansion in platelet lysate increases growth of peripheral blood-derived endothelial-colony forming cells and their growth factor-induced sprouting capacity. PLoS One 10:e0129935
Halliwell B, Zhao K, Whiteman M (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31:651–669
Sawa T, Akaike T, Maeda H (2000) Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem 275:32467–32474
Wong ML, Medrano JF (2005) One-step versus two-step real-time PCR. Biotechniques 39:75–85
Wu J, Hafner C, Schramel JP et al (2016) Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells. Acta Anaesthesiol Scand 60:492–501
Hafner C, Wu J, Soto-gonzalez L et al (2017) Moderate hyperoxia induces inflammation, apoptosis and necrosis in human umbilical vein endothelial cells: an in-vitro study. Eur J Anaesthesiol 34:141–149
Lehle K, Straub RH, Morawietz H, Kunz-schughart LA (2010) Relevance of disease- and organ-specific endothelial cells for in vitro research differences between arterial and venous ECs. Cell Biol Int 34:1231–1238
Jackson WF (2016) Arteriolar oxygen reactivity : where is the sensor and what is the mechanism of action ? J Physiol 18:5055–5077
Kolluru GK, Siamwala JH, Chatterjee S (2010) eNOS phosphorylation in health and disease. Biochimie 92:1186–1198
Ishibazawa A, Nagaoka T, Takahashi T et al (2011) Effects of shear stress on the gene expressions of endothelial nitric oxide synthase, endothelin-1, and thrombomodulin in human retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 52:8496–8504
Spoelstra-de Man AME, Smit B, Oudemans-van Straaten HM, Smulders YM (2015) Cardiovascular effects of hyperoxia during and after cardiac surgery. Anaesthesia 70:1307–1319
Pautz A, Art J, Hahn S et al (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23:75–93
Wang J, Schmidt JR, Roman RJ et al (2010) Modulation of vascular O2 responses by cytochrome 450-4A hydroxylase metabolites in Dahl salt-sensitive rats. Microcirculation 16:345–354
Higgins DR, Hendricks-Munoz DK, Caines VV et al (1998) Hyperoxia stimulates endothelin-1 secretion from entohelial cells; modulation by captopril and nifedipine. Curr Eye Res 17:487–493
Carreau A, El Hafny-Rahbi B, Matejuk A et al (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 15:1239–1253
Hedegaard ER, Stankevicius E, Simonsen U, Fröbert O (2011) Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries. BMC Physiol 11:8
Siegel G, Grote J, Schnalke F, Zimmer K (1989) The significance of the endothelium for hypoxic vasodilatation. Z Kardiol 78:124–131
Eskinder H, Harder DR, Lombard JH (1990) Role of the vascular endothelium in regulating the response of small arteries of the dog kidney to transmural pressure elevation and reduced Po2. Circ Res 66:1427–1436
Van den Bos GC, Westerhof N, Hoogerwerf N, Sicking A (1991) Arteriolar and venular reactivity to superfusate pO2 in tissues with different metabolic capacity. A study in skeletal muscle and mesentery of the rat. Int J Microcirc Clin Exp 10:303–316
Prof.dr. Victor van Hinsbergh is greatly thanked for his advice and help when conceiving the experiments.
Availability of data and materials
The datasets are available from the corresponding author upon reasonable request.
IA performed the experiments, analyzed the data, and drafted the manuscript. YMS, MCW, HMO, and BS contributed to the design of the studies and wrote the manuscript. MHW supervised the laboratory experiments. RJM contributed to the design and analyses of the immunofluorescence experiments. PK and AMES conceived the study and supervised the experiments. All authors read and approved the manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This study was executed in accordance with the Declaration of Helsinki and was approved by the University Human Subjects Committee of the VU University Medical Center, Amsterdam, The Netherlands.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A representative example of oxygen stability during the experiments. The other oxygen percentages used had a similar pattern. Figure S2. The eNOS and the ET-1 experiments of Figs. 3, 4, and 5. displayed as N-fold difference, comparing 10% O2 exposure to 20% O2 (control, set as 1.0) and hyperoxia. Data is expressed mean ± SD; all data non-significant (P > 0.05). (DOCX 266 kb)